Cancer BiologybioRxiv
ATM-deficient lung, prostate and pancreatic cancer cells are acutely sensitive to the combination of olaparib and the ATR inhibitor AZD6738
N. R. Jette, S. Radhamani, R. Ye…·S. P. Lees-MIller
This study shows that ATM-deficient cancer cells are more sensitive to the combination of olaparib and AZD6738, leading to cell death.
DOI 10.1007/s42764-020-00011-0